<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35578855</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1875-5305</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>16</Day>
            </PubDate>
          </JournalIssue>
          <Title>Protein and peptide letters</Title>
          <ISOAbbreviation>Protein Pept Lett</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Potassium Channels Contributes to Apelin-induced Vasodilation in Rat Thoracic Aorta.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.2174/0929866529666220516141317</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Apelin is a newly discovered peptide hormone and originally discovered endogenous apelin receptor ligand.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">In this study, we aimed to investigate the possible roles of potassium channel subtypes in the vasorelaxant effect mechanisms of apelin.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The vascular rings obtained from the thoracic aortas of the male Wistar Albino rats were placed into the isolated tissue bath system. The resting tension was set to 2 g. The aortic rings were precontracted with 10<sup>-5</sup> M phenylephrine (PHE) or 45 mM KCl after the equilibration period. Pyroglutamyl-apelin-13 ([Pyr1]apelin-13), which is the dominant apelin isoform in the human cardiovascular tissues and human plasma, was applied cumulatively (10<sup>-10</sup>-10<sup>-6</sup> M) to the aortic rings in the plateau phase. The experimental protocol was repeated in the presence of specific K+ channel subtype blockers to determine the role of K+ channels in the vasorelaxant effect mechanisms of apelin.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">[Pyr1]apelin-13 induced a concentration-dependent vasorelaxation (p &lt; 0.001). The maximum relaxation level was approximately 52% according to PHE-induced contraction. Tetraethylammonium, iberiotoxin, 4-Aminopyridine, glyburide, anandamide, and BaCl2 statistically significantly decreased the vasorelaxant effect level of [Pyr1]apelin-13 (p &lt; 0.001). However, apamin didn't statistically significantly change the vasorelaxant effect level of [Pyr1]apelin-13.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In conclusion, our findings suggest that BK<sub>Ca</sub>, IK<sub>Ca</sub>, Kv, K<sub>ATP</sub>, Kir, and K<sub>2P</sub> channels are involved in the vasorelaxant effect mechanisms of apelin in the rat thoracic aorta.</AbstractText>
          <CopyrightInformation>CopyrightÂ© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sahinturk</LastName>
            <ForeName>Serdar</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Bursa Uludag University Medicine School, Physiology Department, 16059, Bursa, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Demirel</LastName>
            <ForeName>Sadettin</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Bursa Uludag University Medicine School, Physiology Department, Bursa, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Isbil</LastName>
            <ForeName>Naciye</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Bursa Uludag University Medicine School, Physiology Department, Bursa, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ozyener</LastName>
            <ForeName>Fadil</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Bursa Uludag University Medicine School, Physiology Department, Bursa, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Protein Pept Lett</MedlineTA>
        <NlmUniqueID>9441434</NlmUniqueID>
        <ISSNLinking>0929-8665</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">apelin</Keyword>
        <Keyword MajorTopicYN="N">potassium channels</Keyword>
        <Keyword MajorTopicYN="N">thoracic aorta</Keyword>
        <Keyword MajorTopicYN="N">tissue bath</Keyword>
        <Keyword MajorTopicYN="N">vasorelaxation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>3</Hour>
          <Minute>53</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35578855</ArticleId>
        <ArticleId IdType="doi">10.2174/0929866529666220516141317</ArticleId>
        <ArticleId IdType="pii">PPL-EPUB-123623</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
